Twin-to-twin transfusion syndrome: an antiangiogenic state?

[1]  Wenjiang J. Fu,et al.  A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  H. Stepan,et al.  Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. , 2007, Obstetrics and gynecology.

[3]  B. Sibai,et al.  Soluble endoglin and other circulating antiangiogenic factors in preeclampsia , 2007 .

[4]  E. Chien,et al.  Cytomegalovirus-Induced Mirror Syndrome Associated With Elevated Levels of Circulating Antiangiogenic Factors , 2007, Obstetrics and gynecology.

[5]  R. Romero,et al.  Unexplained fetal death: Another anti-angiogenic state , 2007, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  A. Tabor,et al.  Naturally conceived twins with monochorionic placentation have the highest risk of fetal loss , 2006, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[7]  J. Thurman,et al.  Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction , 2006, The Journal of experimental medicine.

[8]  J. Espinoza,et al.  OC100: The combined use of uterine artery Doppler and maternal plasma placental growth factor concentrations identifies patients at risk for early onset and/or severe pre‐eclampsia , 2006 .

[9]  F. Epstein,et al.  Circulating Angiogenic Factors and Placental Abruption , 2006, Obstetrics and gynecology.

[10]  A. Caughey,et al.  Unequal placental sharing and birth weight discordance in monochorionic diamniotic twins. , 2006, American journal of obstetrics and gynecology.

[11]  Donna D. Johnson,et al.  Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. , 2006, American journal of obstetrics and gynecology.

[12]  E. Gratacós,et al.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[13]  T. Libermann,et al.  Soluble endoglin contributes to the pathogenesis of preeclampsia , 2006, Nature Medicine.

[14]  H. Stepan,et al.  Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. , 2006, The New England journal of medicine.

[15]  F. Epstein,et al.  Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. , 2006, American journal of obstetrics and gynecology.

[16]  D. Hassiakos,et al.  Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. , 2006, Early human development.

[17]  V. Jha,et al.  Low urinary placental growth factor is a marker of pre-eclampsia. , 2006, Kidney international.

[18]  I. Crocker,et al.  An Imbalance Between Vascular Endothelial Growth Factor and its Soluble Receptor in Placental Villous Explants of Intrauterine Growth-Restricted Pregnancies , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[19]  R. Romero,et al.  A role of the anti-angiogenic factor sVEGFR-1 in the ‘mirror syndrome’ (Ballantyne's syndrome) , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[20]  L. Leduc,et al.  Persistance of adverse obstetric and neonatal outcomes in monochorionic twins after exclusion of disorders unique to monochorionic placentation. , 2005, American journal of obstetrics and gynecology.

[21]  G. Creatsas,et al.  Vascular Endothelial Growth Factor and Placenta Growth Factor in Intrauterine Growth-Restricted Fetuses and Neonates , 2005, Mediators of inflammation.

[22]  T. Crombleholme,et al.  Twin-twin transfusion syndrome: where do we go from here? , 2005, Seminars in perinatology.

[23]  N. Fisk,et al.  Insights into the pathophysiology of twin–twin transfusion syndrome , 2005, Prenatal diagnosis.

[24]  T. Lyberg,et al.  Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[25]  R. Frydman,et al.  Selective fetocide reverses preeclampsia in discordant twins. , 2005, American journal of obstetrics and gynecology.

[26]  B. Sachs,et al.  Recent advances in understanding of preeclampsia. , 2005, Croatian medical journal.

[27]  R. Ness,et al.  Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  M. Wolf,et al.  Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. , 2005, Placenta.

[29]  R. Friedman,et al.  Vascular distribution patterns in monochorionic twin placentas. , 2005, Placenta.

[30]  I. Sargent,et al.  Latest Advances in Understanding Preeclampsia , 2005, Science.

[31]  R. Levine,et al.  Circulating Angiogenic Factors in Preeclampsia , 2005, Clinical obstetrics and gynecology.

[32]  S. Maynard,et al.  Soluble Fms-like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia , 2005, Pediatric Research.

[33]  A. LaCroix,et al.  Risk Factors Associated with Acute Pyelonephritis in Healthy Women , 2005, Annals of Internal Medicine.

[34]  R. Romero,et al.  Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia , 2005, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[35]  J. Fahey,et al.  Twin–Twin Transfusion Syndrome: A Population-Based Study , 2004, Obstetrics and gynecology.

[36]  A. Hunter,et al.  Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. , 2004, American journal of obstetrics and gynecology.

[37]  G. PaolaViviani,et al.  Curva nacional de distribución de peso al nacer según edad gestacional: Chile, 1993 a 2000 , 2004 .

[38]  J. Pirhonen,et al.  Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[39]  R. Porreco,et al.  Selective fetocide reverses preeclampsia in discordant twins. , 2004, American journal of obstetrics and gynecology.

[40]  R. Romero,et al.  Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. , 2004, American journal of obstetrics and gynecology.

[41]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. , 2004, Placenta.

[42]  T M Mayhew,et al.  Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. , 2004, Placenta.

[43]  Robert N. Taylor,et al.  First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. , 2004, The Journal of clinical endocrinology and metabolism.

[44]  T. Spector,et al.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies , 2004, The New England journal of medicine.

[45]  H. Augustin,et al.  Prospective Analysis of Placenta Growth Factor (PlGF) Concentrations in the Plasma of Women with Normal Pregnancy and Pregnancies Complicated by Preeclampsia , 2004, Hypertension in pregnancy.

[46]  J. Foidart,et al.  Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. , 2003, The Journal of clinical endocrinology and metabolism.

[47]  B. Luke,et al.  Antenatal factors associated with significant birth weight discordancy in twin gestations. , 2003, American journal of obstetrics and gynecology.

[48]  Y. Taketani,et al.  Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.

[49]  Dirk Timmerman,et al.  Monochorionic diamniotic twins: complications and management options , 2003, Current opinion in obstetrics & gynecology.

[50]  D. Byrne,et al.  Ultrasound Determination of Chorionicity and Perinatal Outcome in Twin Pregnancies Using Dividing Membrane Thickness , 2003, Gynecologic and Obstetric Investigation.

[51]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[52]  R. Frydman,et al.  Selective termination of a twin pregnancy as a treatment of severe pre‐eclampsia , 2003, BJOG : an international journal of obstetrics and gynaecology.

[53]  T. Mayhew.  Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. , 2002, Placenta.

[54]  Y. Wada,et al.  Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. , 2002, Human pathology.

[55]  R. Quintero,et al.  Placental types and twin-twin transfusion syndrome. , 2002, American journal of obstetrics and gynecology.

[56]  K. Alitalo,et al.  Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. , 2002, The American journal of pathology.

[57]  L. Dodds,et al.  Does chorionicity or zygosity predict adverse perinatal outcomes in twins? , 2002, American journal of obstetrics and gynecology.

[58]  C. Ananth,et al.  Placental cord insertion and birth weight discordancy in twin gestations. , 2002 .

[59]  R. Quintero,et al.  Twin–twin transfusion syndrome with only superficial placental anastomoses: endoscopic and pathological evidence , 2002, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[60]  J. Neilson,et al.  Placental regulation of insulin-like growth factor axis in monochorionic twins with chronic twin-twin transfusion syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[61]  H. Ho,et al.  Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. , 2001, American journal of obstetrics and gynecology.

[62]  R. Bajoria,et al.  Discordant fetal leptin levels in monochorionic twins with chronic midtrimester twin-twin transfusion syndrome. , 2001, Placenta.

[63]  N. Sebire,et al.  Twin-to-twin transfusion syndrome results from dynamic asymmetrical reduction in placental anastomoses: a hypothesis. , 2001, Placenta.

[64]  K. Heyborne,et al.  Reversal of Ballantyne syndrome by selective second-trimester fetal termination. A case report. , 2000, The Journal of reproductive medicine.

[65]  N M Fisk,et al.  Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. , 2000, American journal of obstetrics and gynecology.

[66]  M. Gonzalès,et al.  Twin-to-twin transfusion syndrome. Role of the fetal renin-angiotensin system. , 2000, American Journal of Pathology.

[67]  R. Quintero,et al.  Staging of Twin-Twin Transfusion Syndrome , 1999, Journal of Perinatology.

[68]  T. H. Wang,et al.  Preeclampsia is associated with reduced serum levels of placenta growth factor. , 1998, American journal of obstetrics and gynecology.

[69]  R. Bajoria.  Vascular anatomy of monochorionic placenta in relation to discordant growth and amniotic fluid volume. , 1998, Human reproduction.

[70]  N. Fisk,et al.  Haematological indices at fetal blood sampling in monochorionic pregnancies complicated by feto‐fetal transfusion syndrome , 1998, Prenatal diagnosis.

[71]  K. Murphy,et al.  Twin-twin Transfusion Syndrome , 1998 .

[72]  J. Kingdom,et al.  The case for routine determination of chorionicity and zygosity in multiple pregnancy , 1997, Prenatal diagnosis.

[73]  B. Sibai,et al.  Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. , 1997, American journal of obstetrics and gynecology.

[74]  K. Nicolaides,et al.  The hidden mortality of monochorionic twin pregnancies , 1997, British journal of obstetrics and gynaecology.

[75]  A. Many,et al.  Vascular Endothelial Growth Factor Is Increased in Patients With Preeclampsia , 1997, American journal of reproductive immunology.

[76]  I. Greer,et al.  Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre‐eclampsia , 1997, British journal of obstetrics and gynaecology.

[77]  G. Connors,et al.  Evaluation of the Twin Peak or Lambda Sign in Determining Chorionicity in Multiple Pregnancy , 1996, Obstetrics and gynecology.

[78]  K. Nicolaides,et al.  The lambda sign at 10–14 weeks of gestation as a predictor of chorionicity in twin pregnancies , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[79]  J. Himes,et al.  A United States National Reference for Fetal Growth , 1996, Obstetrics and gynecology.

[80]  R. Newman,et al.  Prospective determination of chorionicity, amnionicity, and zygosity in twin gestations. , 1995, American journal of obstetrics and gynecology.

[81]  N. Fisk,et al.  Angioarchitecture of monochorionic placentas in relation to the twin-twin transfusion syndrome. , 1995, American journal of obstetrics and gynecology.

[82]  R. Goldstein,et al.  The Role of Velamentous Cord Insertion in the Etiology of Twin-Twin Transfusion Syndrome , 1993, Obstetrics and gynecology.

[83]  K. Benirschke,et al.  Antenatal origin of neurologic damage in newborn infants. II. Multiple gestations. , 1990, American journal of obstetrics and gynecology.

[84]  D. Pretorius,et al.  Disparity of amniotic fluid volume and fetal size: problem of the stuck twin--US studies. , 1989, Radiology.

[85]  K. Benirschke,et al.  Antenatal origin of neurologic damage in newborn infants: I. Preterm infants , 1988 .

[86]  Gynecologists.  ACOG PRACTICE BULLETIN , 2009 .

[87]  Jing Xu,et al.  Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. , 2008, The Journal of clinical endocrinology and metabolism.

[88]  M. Beckmann,et al.  Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. , 2007, Clinical science.

[89]  L. Tyfield,et al.  Is Zygosity or Chorionicity the Main Determinant of Fetal Outcome in Twin Pregnancies , 2006 .

[90]  Danuta Rajs.  [A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000]. , 2005, Revista médica de Chile (Impresa).

[91]  K. Parker,et al.  Characterisation of deep arterio-venous anastomoses within monochorionic placentae by vascular casting. , 2005, Placenta.

[92]  P. Taylor,et al.  J Soc Gynecol Investig , 2005 .

[93]  R. Bajoria,et al.  Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight. , 2004, American journal of obstetrics and gynecology.

[94]  R. Bajoria,et al.  Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome. , 2002, American journal of obstetrics and gynecology.

[95]  R. Quintero,et al.  The donor-recipient (D-R) score: In vivo endoscopic evidence to support the hypothesis of a net transfer of blood from donor to recipient in twin- twin transfusion syndrome , 2000 .

[96]  B. Sibai,et al.  Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. , 1997, American journal of obstetrics and gynecology.

[97]  G. Machin.  Velamentous cord insertion in monochorionic twin gestation. An added risk factor. , 1997, The Journal of reproductive medicine.